WCLC 2025 - Posters & ePosters-PT2.10.04 Efficacy and Safety of TQB2102, a Biparatopic HER2-Targeting ADC, in HER-2 Aberrant NSCLC: A Phase II Study

PT2.10.04 Efficacy and Safety of TQB2102, a Biparatopic HER2-Targeting ADC, in HER-2 Aberrant NSCLC: A Phase II Study

Asset Subtitle

Li Zhang

Meta Tag

Speaker Li Zhang

Topic Metastatic Non-small Cell Lung Cancer – Cytotoxic Therapy